Evidence map›Paper›PMID 31382730›Full record

ArticleKidney research and clinical practice2019

Impact of chronic kidney disease on mortality: A nationwide cohort study.

Kyeong Min Kim, Hyung Jung Oh, Hyung Yun Choi, Hajeong Lee, Dong-Ryeol Ryu

Abstract read
In one paragraph

Article in Kidney research and clinical practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Comorbidity patterns and mortality in HFpEF: A retrospective longitudinal cohort study.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Interactive exploration of adverse events and multimorbidity in CKD.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kyeong Min KimESRD Registry Committee, Korean Society of Nephrology, Seoul, Korea.ORCID http://orcid.org/0000-0002-5414-4339
Hyung Jung OhESRD Registry Committee, Korean Society of Nephrology, Seoul, Korea.ORCID http://orcid.org/0000-0002-4281-696X
Hyung Yun ChoiESRD Registry Committee, Korean Society of Nephrology, Seoul, Korea.ORCID http://orcid.org/0000-0002-6134-3504
Hajeong LeeESRD Registry Committee, Korean Society of Nephrology, Seoul, Korea.ORCID http://orcid.org/0000-0002-1873-1587
Dong-Ryeol RyuESRD Registry Committee, Korean Society of Nephrology, Seoul, Korea.ORCID http://orcid.org/0000-0002-5309-7606

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMortality is higher in patients with chronic kidney disease (CKD) than in the general population, but little information is available on CKD-related mortality that is representative of the Korean population. Our objective was to investigate mortality risk in Korean patients with CKD.

methodsWe identified patients with incident CKD who had not undergone dialysis or kidney transplantation between January 1, 2003 and December 31, 2007 in Korea using the database of the Korean National Health Insurance Service-National Sample Cohort, and stratified the population into the following three groups: group 1 (n = 1,473), controls; group 2 (n = 2,212), patients with diabetes or hypertension, but without CKD; and group 3 (n = 2,212), patients with CKD. We then monitored them for all-cause mortality until December 2013.

resultsA total of 1,473 patients were included in this analysis. During the follow-up period, 941 patients in group 3 died (134 deaths/1,000 person-years) compared with 550 deaths in the group 2 (34 deaths/1,000 person-years) and 459 deaths in group 1 (30 deaths/1,000 person-years). The rate ratio for mortality rate was 4.5, and the hazard ratio for mortality was 4.88 (95% confidence interval [CI], 4.36-5.47,

conclusionIn this nationally representative sample cohort, excess mortality was observed in Korean patients with incident CKD.

Indexed as

chronicDiabetes mellitusHypertensionKoreaMortalityRenal insufficiency

Identifiers

PMID31382730
PMCPMC6727899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.